文献速递膀胱癌与上尿路尿路上皮癌

回肠导管术中预防性补片放置的成本效果分析

Prophylactic Mesh Placement With Ileal Conduit: A Cost-effectiveness Analysis.
PubMed 文献 · Urology · 2023-04-28

本研究通过构建马尔可夫模型,评估膀胱癌根治性膀胱切除加回肠导管术时预防性放置补片的经济性。结果显示,在I至IV期膀胱癌患者中,补片组虽更昂贵但能提供更多质量调整生命年,增量成本效果比为每QALY 2114.71美元,具有成本效果。

要点

  • 在I至IV期膀胱癌患者中,预防性补片放置较不放补片更贵但更有效。
  • 两策略平均增量成本为897美元,平均增量效果为0.49个QALY。
  • 增量成本效果比为每QALY 2114.71美元,敏感性分析显示补片获益对补片感染概率敏感。

核心结论

  • 对于因膀胱癌行回肠导管尿流改道的患者,根治性膀胱切除时预防性放置补片是预防造口旁疝的总体具有成本效果的策略,适用于所有分期的膀胱癌患者。

研究设计与样本

  • 构建马尔可夫模型,纳入根治性膀胱切除加回肠导管术患者预防性补片的成本与效果,成本来自文献并调整至2022年美元,效果以质量调整生命年(QALY)衡量,并进行一维和二维敏感性分析检验模型稳健性。

主要发现

  • 在I至IV期膀胱癌中,预防性补片放置较索引手术时不放补片成本更高但提供更多生活质量。
  • 两策略在所有分期中的平均增量成本为补片组额外897美元,平均增量效果为额外0.49个QALY。
  • 增量成本效果比为每QALY 2114.71美元。
  • 敏感性分析表明补片放置的获益对补片感染概率敏感。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the cost-effectiveness of mesh placement in patients undergoing ileal conduit urinary diversion for bladder cancer. Long-term studies have shown that parastomal hernias (PSH) occur in more than half of all stomas. Mesh prophylaxis has been shown to reduce PSH after end-colostomy and ileal conduits. However, no cost-effectiveness studies on mesh prophylaxis have been performed for this population. METHODS: We created a Markov model incorporating the costs and effectiveness of mesh prophylaxis for patients undergoing radical cystectomy and ileal conduit construction. Costs were obtained from the literature and adjusted to 2022 US dollars. Effectiveness was measured in quality-adjusted life years (QALY). 1- and 2-way sensitivity analyses were performed to test the robustness of our model. RESULTS: In stage I-IV bladder cancer, prophylactic mesh placement was costlier, but more effective in providing quality of life compared with no mesh placement at index surgery. Average incremental cost between the 2 strategies across all stages was an additional $897 when mesh was utilized. Incremental effectiveness averaged 0.49 additional QALY across all stages. This resulted in an incremental cost-effectiveness ratio of $2114.71/QALY. Sensitivity analyses indicated that benefit of mesh placement was sensitive to the probability of mesh infection. CONCLUSION: In patients undergoing ileal conduit urinary diversion for bladder cancer, mesh prophylaxis at the time of radical cystectomy is an overall cost-effective strategy in preventing PSH for patients presenting with all stages of bladder cancer.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Kanabolo DL, Park S. Prophylactic Mesh Placement With Ileal Conduit: A Cost-effectiveness Analysis. Urology. 2023. PMID: 37119979. doi:10.1016/j.urology.2023.03.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。